Kashyap Tele-Medicines Limited

As of March 31, 2026, Kashyap Tele-Medicines Limited has 47.72M shares outstanding.

These figures are as of March 31, 2026. The price-to-sales ratio is 122.50, and the price-to-book ratio stands at 5.06.

These figures are as of March 31, 2026. The EV/Sales ratio of 119.41 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative.

As of March 31, 2026, Kashyap Tele-Medicines Limited maintains a current ratio of 1.40, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended March 31, 2026, Kashyap Tele-Medicines Limited posted a negative return on equity (ROE) of -9.65, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -71.95, reflecting losses generated across the asset base.

Over the twelve months ended March 31, 2026, Kashyap Tele-Medicines Limited posted a gross margin of 90.30, reflecting its pricing power and cost economics. The operating margin of -243.35 and net profit margin of -233.81 provide insight into operational efficiency.

As of March 31, 2026, Kashyap Tele-Medicines Limited has an Altman Z-Score of 31.12, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.